SISSA DIGITAL LIBRARYInstitutional Research Information System (Statistiche: prodotti, OA)
Per informazioni contatta sdl@sissa.it

Legname, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.893
EU - Europa 13.867
AS - Asia 3.666
Continente sconosciuto - Info sul continente non disponibili 111
OC - Oceania 22
SA - Sud America 22
AF - Africa 12
Totale 31.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.298
IT - Italia 2.790
SE - Svezia 2.734
IE - Irlanda 2.385
CN - Cina 2.045
RU - Federazione Russa 1.615
UA - Ucraina 1.432
GB - Regno Unito 800
TR - Turchia 798
DE - Germania 775
CA - Canada 593
HK - Hong Kong 490
FI - Finlandia 465
FR - Francia 290
VN - Vietnam 140
CH - Svizzera 127
EU - Europa 108
BE - Belgio 93
AT - Austria 82
GR - Grecia 59
LB - Libano 50
NL - Olanda 40
RO - Romania 39
PL - Polonia 31
UZ - Uzbekistan 29
CZ - Repubblica Ceca 24
ES - Italia 23
IN - India 22
KR - Corea 20
JP - Giappone 16
SG - Singapore 16
LU - Lussemburgo 13
NZ - Nuova Zelanda 12
AU - Australia 10
BR - Brasile 10
MD - Moldavia 10
PT - Portogallo 10
IL - Israele 7
DK - Danimarca 5
HR - Croazia 5
ID - Indonesia 5
CL - Cile 4
HU - Ungheria 4
SI - Slovenia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
LK - Sri Lanka 3
NO - Norvegia 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TZ - Tanzania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AR - Argentina 2
BG - Bulgaria 2
DZ - Algeria 2
KE - Kenya 2
KZ - Kazakistan 2
PH - Filippine 2
PK - Pakistan 2
SC - Seychelles 2
A1 - Anonimo 1
AL - Albania 1
BD - Bangladesh 1
BT - Bhutan 1
CU - Cuba 1
EC - Ecuador 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
IQ - Iraq 1
IR - Iran 1
LV - Lettonia 1
MT - Malta 1
MX - Messico 1
NG - Nigeria 1
PE - Perù 1
RS - Serbia 1
TN - Tunisia 1
Totale 31.593
Salva come PNG Salva come JPEG
Città #
Chandler 2.689
Dublin 2.384
Jacksonville 1.780
Scuola 1.668
Ann Arbor 1.211
Wilmington 905
New York 825
Ashburn 813
Izmir 789
Saint Petersburg 729
Nanjing 629
Toronto 561
Woodbridge 511
Hong Kong 483
Princeton 330
Dearborn 320
Pisa 300
Houston 275
Nanchang 250
Ogden 236
Beijing 207
Helsinki 197
Brooklyn 134
Dong Ket 130
Milan 126
Kunming 122
Sauris 104
Falls Church 97
Tianjin 95
Brussels 91
Trieste 84
Hebei 76
Seattle 76
Shenyang 75
Changsha 68
Hangzhou 60
Verona 56
Lausanne 54
Jiaxing 53
Vienna 53
Boardman 42
Changchun 42
Washington 42
Orange 38
Frankfurt Am Main 37
Strasbourg 37
Moscow 36
Lanzhou 34
Dongguan 33
Hanover 32
Timisoara 31
Las Vegas 29
Ningbo 28
Redwood City 28
Rome 26
Jinan 24
Shanghai 24
Torino 24
Zhengzhou 22
Costa Mesa 21
Borås 19
Guangzhou 19
Hefei 19
Auburn Hills 18
Norwalk 17
Redmond 17
Taizhou 17
Düsseldorf 16
Udine 16
Den Haag 15
Los Angeles 15
Frankfurt am Main 14
Grafing 14
San Francisco 11
Southend 11
Boston 10
Chicago 10
Chisinau 10
Mamer 10
Ottawa 10
Bologna 9
Chengdu 9
Edmonton 9
Paris 9
Plauen 9
San Jose 9
Tokyo 9
Turin 9
Bremen 8
Candelo 8
Hanoi 8
Mountain View 8
Rockville 8
Sacramento 8
Ulan-ude 8
Blanes 7
London 7
Muggiò 7
Phoenix 7
Trento 7
Totale 20.727
Salva come PNG Salva come JPEG
Nome #
Brain aging: A Ianus-faced player between health and neurodegeneration 206
Characterization of prion protein function by focal neurite stimulation 171
Nanoparticelle di oro rivestite con polielettroliti e loro uso come medicamento per il trattamento di malattie neurodegenerative causate da aggregati proteici 170
alpha-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication 165
Cellular prion protein: Role in excitotoxicity and in metal ions homeostasis 164
Structural features of human prion protein variants revealed by NMR 163
Detection of prion seeding activity in the olfactory mucosa of patients with Fatal Familial Insomnia 162
Processo per la preparazione di proteine inibenti i ribosomi 160
Developmental prion protein expression in eutherian and methaterian mammalian central nervous system 158
Synthetic mammalian prions 157
The non-octarepeat copper binding site of the prion protein is a key regulator of prion conversion 154
Anti-prion activity generated by two soil compounds-Humic and fulvic acids 153
Prion protein and copper cooperatively protect neurons by modulating NMDA receptor through S-nitrosylation 151
Whole blood gene expression profiling in preclinical and clinical cattle infected with atypical bovine spongiform encephalopathy 151
Serpin inhibitors for the treatment of prion and prion-like diseases 151
Synthetic prions with novel strain-specified properties 150
Gene Expression Profiling of Prion-Infected Brains: a Novel Disease Signature for Neurodegeneration in Humans 150
Nucleotide sequences coding for ribosome inactivating proteins 149
Altered Brain Hemoglobin Gene Expression in the Frontal Cortex of Patients with Alzheimer’s and Acquired Creutzfeldt-Jakob’s Disease 149
Differential overexpression of SERPINA3 in human prion diseases 149
Cloning and characterization of a gene, inducible by cytokines 147
A new approach to follow a single extracellular vesicle-cell interaction using optical tweezers 145
Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations 144
Humic substances underlies the odds of environmental TSEs transmission 143
Hemoglobin mRNA changes in the frontal cortex of patients with neurodegenerative diseases 142
The N Terminus of the Prion Protein Mediates Functional Interactions with the Neuronal Cell Adhesion Molecule (NCAM) Fibronectin Domain 141
Recent Advances of Biology and Medicinal Chemistry of Prion Protein and Prions: On the Road to Therapeutics 140
A structural characterization of recombinant mouse prion protein amyloid fibers 139
Synthetic prions and other human neurodegenerative proteinopathies 139
Preface 138
Synthetic prions: De novo prion-infected neuronal cell lines and the generation of diverse infectious materials 137
Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaques 135
Prion protein interaction with soil humic substances: environmental implications 135
Cloning and characterization of a gene, inducible by cytokines 135
Effects of tetrahydrocannabinol on melatonin secretion in man 134
NMR Structures of the Human Prion Protein with Pathological Mutations: Insights Into Molecular Basis of Prion Disease 134
Whole transcriptome analysis in brains from BSE-infected macaques 132
Method of amplifying infectious proteins 131
NMR structure of the human prion protein with the pathological Q212P mutation: insights into inherited human prion diseases 130
Defined α-synuclein prion-like molecular assemblies spreading in cell culture 128
The mechanisms of humic substances self-assembly with biological molecules: The case study of the prion protein 128
Oriented immobilization of prion protein demonstrated via precise interfacial nanostructure measurements 127
A search for auxiliary proteins in prion replication 127
Developmental role of the prion protein in the nervous system 127
Humic substances and therapeutic uses thereof 126
Brain delivery of AVV9 expressing anti-PrP molecules delays prion disease onsite in mice 126
Effect of extracellular vesicles derived from distinct brain cells on A beta toxicity and assembly: focus on microglia derived vesicles 126
Pin1 and neurodegeneration: a new player for prion disorders? 126
Prion protein and aging 125
Soil humic substances hinder the propagation of prions 125
Nucleotide sequence coding for ribosome inactivating proteins 125
Identification of novel fluorescent probes preventing PrPSc replication in prion diseases 125
In Vitro Aggregation Assays for the Characterization of α-synuclein Prion-Like Properties 124
The amino-terminal-fragment of human urokinase fused to the plant toxin saporin targets the recombinant fusion toxin to urokinase-receptor bearing-cells: is internalization mediated by the toxin? 124
De novo generation of mammalian prions 123
Ligands binding to prion protein for use in the treatment of synucleinopathies 123
Prions 122
Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper binding site 121
Molecular pathogenesis of prion diseases 120
Humic substances and uses thereof in agro-environment 120
Nanobody-stabilize the crystal structure of full-length human PrP 120
Cytosolic localization of prion protein in neuronal cells in brain of mice 119
In Absence of the Cellular Prion Protein, Alterations in Copper Metabolism and Copper-Dependent Oxidase Activity Affect Iron Distribution 118
Induction of Protease-Resistant Prion Protein and alpha-synuclein Aggregation by Human alpha-synuclein Fibrils in Cultured Cells 118
Methionine oxidation in α-synuclein inhibits its propensity for ordered secondary structure 118
Pathogenesis of Prion Diseases 117
Structural Variations of Prion Proteins Caused by Mutations in Human Genome 117
Conformational properties of intrinsically disordered proteins bound to the surface of silica nanoparticles 117
Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper-binding site 117
Structural determinants in prion protein folding and stability 116
Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation 116
Design of ligands with a high affinity to the cellular form of the prion protein 116
New insights into structural determinants of prion protein folding and stability 116
Nucleotide sequences coding for ribosome inactivating proteins 115
The Prion Concept and Synthetic Prions 115
Human α-synuclein fibrils induce α-synuclein aggregation in vitro and behavioral alterations in vivo upon inoculation in wildtype mice 114
AGFD 199 - Isolation and characterization of new anti-PrP monoclonal antibodies 114
Description and Characterization of a Highly Stable Enthalpic Intermediate State in Mouse Prion Protein Folding 113
Anti-GM1 IgM antibodies in motor neuron disease (MND) and other neurological diseases 113
Developmental influence of the cellular prion protein on the gene expression profile in mouse hippocampus 113
Modulation of Prion by Small Molecules: From Monovalent to Bivalent and Multivalent Ligands 113
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer’s and Prion Diseases 112
Altered molecular signaling in neuronal cell models of prion infection 112
Inferring prion partners from Gene-Networks 112
The role of the prion protein in the internalization of α-synuclein amyloids 111
Antemortem Prion Diagnostics 110
NMR structure of the human prion protein Q212P mutant 110
Synthetic human alpha-synuclein prions 110
Styrylquinoline derivatives potentially useful as diagnostic and therapeutic agents in misfolding diseases 110
Antagonistic cellular functions for prion protein and its paralog doppel. 109
Elucidating the function of the prion protein 109
Single-chain ribosome inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA 109
Nanobody-Assisted Crystallization of Human and Mouse Prion Proteins 108
SAXS structural study of PrPSc reveals similar to 11 nm diameter of basic double intertwined fibers 108
De novo mammalian prion synthesis 107
Synthetic prions 107
Trasmissible Spongiform Encephalopathies 107
Mouse synthetic prions from full-length prion protein 107
Prion Biology and Disease: The Making of Synthetic Prions 107
Infrared microspectroscopy: A multiple-screening platform for investigating single-cell biochemical perturbations upon prion infection 106
Totale 12.928
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.226
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.886 0 0 0 0 0 0 0 0 0 0 290 1.596
2019/20204.572 610 374 833 70 364 228 813 375 357 168 344 36
2020/20213.585 441 94 33 332 66 677 471 24 395 382 149 521
2021/20223.292 483 370 18 334 568 94 202 365 144 107 195 412
2022/20238.209 1.218 896 735 782 431 1.663 883 528 769 62 114 128
2023/20244.548 279 71 178 82 708 1.960 184 261 739 66 20 0
Totale 32.904